Не сдохни! Еда в борьбе за жизнь

^{‹‹104››.} Crane MG, Sample C. Regression of diabetic neuropathy with total vegetarian (vegan) diet. J Nutr Med. 1994;4(4):431–9.

^{‹‹105››.} Crane MG, Sample C. Regression of diabetic neuropathy with total vegetarian (vegan) diet. J Nutr Med. 1994;4(4):431–9.

^{‹‹106››.} Rabinowitch IM. Effects of the high carbohydrate-low calorie diet upon carbohydrate tolerance in diabetes mellitus. Can Med Assoc J. 1935;33(2):136–44.

^{‹‹107››.} Newborg B, Kempner W. Analysis of 177 cases of hypertensive vascular disease with papilledema; one hundred twenty-six patients treated with rice diet. Am J Med. 1955;19(1): 33–47.

^{‹‹108››.} Crane MG, Sample C. Regression of diabetic neuropathy with total vegetarian (vegan) diet. J Nutr Med. 1994;4(4):431–9.

^{‹‹109››.} Crane MG, Sample C. Regression of diabetic neuropathy with total vegetarian (vegan) diet. J Nutr Med. 1994;4(4):431–9.

^{‹‹110››.} Crane MG, Sample C. Regression of diabetic neuropathy with total vegetarian (vegan) diet. J Nutr Med. 1994;4(4):431–9.

^{‹‹111››.} Crane MG, Zielinski R, Aloia R. Cis and trans fats in omnivores, lacto-ovo vegetarians and vegans. Am J Clin Nutr. 1988;48:920.

^{‹‹112››.} Tesfaye S, Chaturvedi N, Eaton SEM, et al. Vascular risk factors and diabetic neuropathy. N Engl J Med. 2005;352(4):341–50.

^{‹‹113››.} Newrick PG, Wilson AJ, Jakubowski J, et al. Sural nerve oxygen tension in diabetes. Br Med J (Clin Res Ed). 1986;293(6554):1053–4.

^{‹‹114››.} McCarty MF. Favorable impact of a vegan diet with exercise on hemorheology: implications for control of diabetic neuropathy. Med Hypotheses. 2002;58(6):476–86.

^{‹‹115››.} Kempner W, Peschel RL, Schlayer C. Effect of rice diet on diabetes mellitus associated with vascular disease. Postgrad Med. 1958;24(4):359–71.

^{‹‹116››.} McCarty MF. Favorable impact of a vegan diet with exercise on hemorheology: implications for control of diabetic neuropathy. Med Hypotheses. 2002;58(6):476–86.

^{‹‹117››.} Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0·5 could be a suitable global boundary value. Nutr Res Rev. 2010;23(2):247–69.

^{‹‹118››.} Bigaard J, Tjønneland A, Thomsen BL, Overvad K, Heitmann BL, S, Sørensen TI. Waist circumference, BMI, smoking, and mortality in middle-aged men and women. Obes Res. 2003; 11(7): 895–903.

^{‹‹119››.} Bigaard J, Tjønneland A, Thomsen BL, Overvad K, Heitmann BL, S, Sørensen TI. Waist circumference, BMI, smoking, and mortality in middle-aged men and women. Obes Res. 2003; 11(7): 895–903.

^{‹‹120››.} Leitzmann MF, Moore SC, Koster A, et al. Waist circumference as compared with body-mass index in predicting mortality from specific causes. PLoS One. 2011;6(4):e18582.

^{‹‹121››.} Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0·5 could be a suitable global boundary value. Nutr Res Rev. 2010;23(2):247–69.

^{‹‹122››.} Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta, GA: U.S. Department of Health and Human Ser vices; 2014. http://www.cdc.gov/diabetes/data/statistics/2014StatisticsReport.html. Updated October 24, 2014. Accessed March 6, 2015.

^{‹‹123››.} Nathan DM, Davidson MB, Defronzo RA, et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care. 2007;30(3):753–9.